Early stage clinical trial results show the Covid-19 vaccine candidate made by Novavax is safe and elicits an immune response, according to a study published Wednesday in The New England Journal of Medicine. The results had previously been announced by the company in early August.
from CNN.com - RSS Channel - App International Edition https://ift.tt/3gVB9ZH
Wednesday, September 2, 2020
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment